At Roche you can show up as yourself, embraced for the unique qualities you bring. Our culture encourages personal expression, open dialogue, and genuine connections, where you are valued, accepted and respected for who you are,
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Salary Range:CHF122,500.00 - CHF227,500.00 BandLevel 5 Job Description SummaryHelp shape how Novartis scientists discover the next generation of medicines. As Delivery Lead for Analysis & Design, youll bring the platforms that turn experimental and computational data into
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
The Opportunity: Avantor is looking for a dedicated Applications Support Specialist to join our team in Basel. This role encompasses the development and maintenance of custom applications provided as a service to internal stakeholders, alongside the
IT Security Engineer sciCORE is the center of competence for scientific computing at the University of Basel, the oldest university in Switzerland and consistently ranked among the best universities in the world. The University is highly research-oriented,
Your position Act as the primary security subject matter expert for sciCORE infrastructures and research-support services Contribute proactively to the secure architecture and operation of sciCORE services, including security-related tools, HPC systems, web applications, trusted research environments (sciCORE+),
sciCORE is the center of competence for scientific computing at the University of Basel, the oldest university in Switzerland and consistently ranked among the best universities in the world. The University is highly research-oriented, with particular
Organisation/Company University of Basel Research Field Computer science Other Researcher Profile First Stage Researcher (R1) Application Deadline 11 Jul 2026 - 21:59 (UTC) Country Switzerland Type of Contract Temporary Job Status Full-time Is the job funded through
About the Hiring Process One application can unlock multiple opportunities. Our AI-powered matching platform considers your profile not only for this role, but also for other relevant opportunities across our client network. We only advertise genuine, active
Viking (NYSE: VIK) is a global leader in experiential travel with a fleet of more than 100 ships, exploring 21 rivers, five oceans and all seven continents. Designed for curious travelers with interests in science, history,
Please note that we can only accept applicants who are eligible to work in Europe or in possession of a valid work permit. Second Engineer River - Nautic Viking (NYSE: VIK) was founded in 1997 and
Location: Basel, Switzerland • Hybrid 3 days/week in office Internal job title: Associate Director, Agentic AI Solutions Product Manager About the Role We are seeking a Product Manager Agentic AI Solutions to lead the product strategy,
Viking (NYSE: VIK) was founded in 1997 and provides destination-focused journeys on rivers, oceans and lakes around the world. Designed for curious travelers with interests in science, history, culture and cuisine, Chairman and CEO Torstein Hagen